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ABSTRACT The distribution of cell surface heparan sulfate proteoglycans (HSPGs) was determined 
in rat liver by immunocytochemistry. A polyclonal antibody was raised against HSPGs purified from 
rat liver microsomes which specifically immunoprecipitated liver membrane HSPGs. It was shown 
to recognize both the heparin-releasable and membrane-intercalated form of membrane HSPGs and 
to recognize determinants on the core protein of these HSPGs. By immunocytochemistry membrane 
HSPGs were localized to hepatocytes. The distribution of HSPGs at the cell surface of the hepatocyte 
was restricted to the sinusoidal domain of the plasmalemma; there was little or no staining of the 
lateral or bile canalicular domains. Intracellularly, HSPGs were occasionally detected in cisternae of 
the rough endoplasmic reticulum and were regularly found in Golgi cisternae--usually distributed 
across the entire Golgi stack. HSPGs were also localized in some endosomes, lysosomes, and 
cytoplasmic vesicles of hepatocytes. We conclude that the HSPGs recognized by this antibody have 
a restricted distribution in rat liver: they are largely confined to the sinusoidal plasmalemmal domain 
and to biosynthetic and endocytic compartments of hepatocytes. 
Heparan sulfate proteoglycans (HSPGs) ~ are widely distrib- 
uted in mammalian tissues and cell cultures. They have been 
found in association with cell surfaces (1-5), intracellular 
organdies (6, 7), and extracellular matrices (especially base- 
ment membranes) (8-11), and have been proposed to partic- 
ipate in a variety of functions uch as cell-cell interactions 
(12), cell migration (13), and cell adhesion (14, 15). HSPGs 
isolated from different sources have distinct structures in 
terms of their overall size (70-400 kD) and the size of their 
glycosaminoglycan chains (14-70 kD). 
One of the best characterized populations of HSPGs are 
those isolated from rat liver membranes (3, 15). These HSPGs 
are relatively small (75 kD) and consist of a core protein with 
about four attached heparan sulfate (HS) side chains (14 kD). 
Three forms of HSPG have been purified from rat liver 
membranes (3, 16) and from primary hepatocyte cultures (15, 
17)--one that behaves as a peripheral membrane protein in 
that it can be displaced from cells by exogenous heparin, 
another that behaves as an integral membrane protein in that 
Abbreviations used in this paper." ER, endoplasmic reticulum; HS, 
heparan sulfate; HSPGs, heparan sulfate proteoglycans; PMs, plasma 
membrane fractions. 
its core protein is intercalated into the lipid bilayer, and a 
third form, recently characterized, which consists of HS oli- 
gosaccharides and is believed to be associated with lysosomes 
(Kj611en, L., H. Pertofi, A. Oldberg, M. H66k, submitted for 
publication). The heparin-displacable and membrane-inter- 
calated forms are known to be present in rat liver microsomal 
and plasma membrane fractions, but their precise localization 
in rat liver in situ is unknown. 
In this study, an antibody was generated against rat liver 
membrane HSPGs and used to determine the distribution of 
these HSPGs in rat liver. 
MATERIALS AND METHODS 
Materials: Molecular weight standards for SDS PAGE and Sepharose 
4B-Protein A beads were obtained from Pharmacia Fine Chemicals (Uppsala, 
Sweden). lodobeads were obtained from Pierce Chemical Co. (Rockford, IL), 
and Na[t2~I] was obtained from Amersham Corp. (Arlington Heights, IL). Fab 
fragments of sheep anti-rabbit IgG conjugated to horseradish peroxidase were 
obtained from the Institute Pasteur Productions (Marnes La Coquette, France). 
3,3 diaminobenzidine and pepstatin A were obtained from Sigma Chemical 
Co. (St. Louis, MO). Fluorescein isothiocyanate-conjugated rabbit anti-goat 
IgG and goat anti-rabbit F(ab')2 were obtained from Cappel Laboratories, Inc. 
(Cochranville, PA), and l0 nm colloidal gold coupled to sheep anti-rabbit IgG 
was obtained from Janssen Life Science Products (Piscataway, N J). Platelet- 
derived heparitinasc was prepared as previously described (3). 
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Preparation of Antiserum: HSPGs were purified from rat liver 
microsomes bygel chromatography, ion exchange chromatography, and density 
gradient ultracentrifugation (3).Purity was assessed by enzymatic degradation. 
analytical centrifugation, and amino acid analysis (3). An amount correspond- 
ing to 25 ug protein (in 100 #l) was emulsified in complete Freund's adjuvant 
(100 ul) and injected (50-~1 aliquots) into the popliteal lymph nodes of a rabbit. 
Booster injections in incomplete Freund's adjuvant were given twice at 2-wk 
intervals. The rabbit was bled 10, 20, and 30 d after the last injection, and the 
antiserum was screened for reactivity to HSPGs by immunoprecipitation as 
described below, lgO was isolated from the antiserum by affinity chromatog- 
raphy on Protein A-Sepharose (l 8). 
Preparation of 1251-HSPGs and 12sI-PMs: Plasma membrane 
fractions (PMs) (19) and membrane HSPGs (16) were prepared from rat livers 
as detailed previously, and radioiodinated by the Chloramine T method using 
Iodobeads. ~251-PMs were solubilized in I% Triton X-100, in phosphate- 
buffered saline (PBS). 
Preparation of [35S]Sulfate I-ISPG: Primary cultures of rat hepa- 
tocytes were radiolabeled with 100 t~Ci/ml of [3~S]sulfate for24 h as previously 
described (15). Protease inhibitors, phenylmethylsulfonyl fluoride (l mM), n- 
ethylmaleimide (2 mM), EDTA (2 mM), and pepstatin ( l0 t~g/ml), were present 
in all buffers used for isolation of HSPGs. The radiolabeled cells were incubated 
with 0.5 mg/ml heparin to displace receptor-bound HSPGs (15) which were 
collected, and the cells were further incubated with 1% Triton X-100 in 0.05M 
Tris buffer (pH 8.0) for 30 min at 25"C to release membrane-intercalated 
HSPGs and HS polysaccharide. After centrifugation (to pellet unsolubilized 
material), HSPGs were purified from the detergent extract nd from heparin- 
displaced fractions by DEAE-ion exchange chromatography and gel chroma- 
tography on Sepharose CL-4B (16). The membrane-intercalated HSPGs and 
HS oligosaccharide are separated in the latter step. 
Immunoprecipitation: ~251-HSPGs (3 #g protein) or ~2~I-PMs (2 #g) 
were incubated at 4oc overnight with IO0 #l of normal or immune rabbit serum 
in PBS containing 0.1% Triton X-100 and 5 mg/ml bovine serum albumin in 
a total volume of 1 ml. 3~S-HSPGs or HS (5,000 clam) were incubated under 
similar conditions with varying amounts of IgG. After addition of 100 #l of a 
l/1 suspension of Protein A-Sepharose in PBS and further incubation for l h 
at room temperature, the beads were pelleted by centrifugation, washed with 
4 x I ml of PBS containing 0.5 M NaCl and 0.1% Triton X-100, and assayed 
for ~251- or 35S-radioactivity. 
SDS PAGE: Immunoprecipitates obtained from J25I-labeled samples 
were solubilized and analyzed on 7-15% polyacrylamide gradient gels with a 
4.8% stacking gel in a Maisel buffer system as described by BIobel and 
Dobberstein (20). After fixation in 12% trichloroacetic acid, gels were stained 
with Coomassie Blue, and autoradiographed using Kodak X-Omat AR films. 
Exposure was at -700C for 3 d. 
Preparation of Tissue for Immunocytochemistry: Procedures 
used for the fixation and incubation of rat liver were as described in an earlier 
paper (21). In brief, fixation was initiated by perfusion with periodate-lysine- 
paraformaldehyde, and blocks of tissue were excised and immersed inthe same 
fixative for an additional ,1-6 h at 25"C. 
Immunofluorescence: Frozen sections (0.5 um) were prepared from 
periodate-lysine-paraformaldehyde-fixed rat liver on a Reichert Ultracut OMU- 
4 ultramicrotome equipped with a cryoattachment. Sections were mounted on 
glass slides and incubated sequentially in (a) normal rabbit serum or anti- 
HSPG antiserum or IgG, (b) fluorescein isothiocyanate goat anti-rabbit F(ab')2, 
and (c) fluorescein isothiocyanate rabbit anti-goat IgG (to enhance the fluores- 
cent signal); sections were then examined in a Zeiss Photomicroscope II 
equipped with epifluorescence. 
Immunoperoxidase: Procedures used for indirect immunoperoxi- 
dasc staining were given elsewhere (21-23). In brief, cryostat sections (15-20 
urn) were prepared from periodate-lysine-paraformaldehyde-fixed liver and 
incubated in (a) normal rabbit or immune serum (diluted Ys) or IgG (3 #g/ml) 
for 12-16 h and (b) peroxidase-conjugated sh ep anti-rabbit Fab (2 h). Sections 
were then fixed in 1.5% glutaraldehyde, incubated in diaminobenzidine me- 
dium, postfixed in ferrocyanide-reduced OsO4 and embedded in Epon. 
Immunogold: Cryostat sections were incubated in immune or preim- 
mune serum as above and then in sheep anti-rabbit-gold conjugate (24--48 h), 
postfixed in 1% OsO4 in acetate-veronal buffer, stained in block with uranyl 
acetate, and embedded in Epon. 
RESULTS 
Immunoprecipitation of1251-HSPGs 
When f ract ions o f  ~251-HSPGs pur i f ied f rom rat l iver p lasma 
membranes  (composed  o f  a mix ture  o f  membrane- in terca -  
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lated and  hepar in - re leasab le  HSPGs)  were incubated  with the 
ant ibody ,  30% o f  the  ~2~I counts  were precip i tated,  whereas  
on ly  2% were prec ip i tated wi th  contro l  serum.  When PMs  
were iod inated  and  the so lubi l ized prote ins  were used for 
immunoprec ip i ta t ion ,  on ly  background amounts  o f  radioac-  
t ivity were prec ip i tated with e i ther  immune or normal  rabbi t  
serum.  Prev ious  exper iments  have  establ ished that  this is 
because  no  detectable  amount  o f  ~25I-radioactivity is incor-  
porated  into HSPGs  when intact  PMs  are iod inated  (Kjr l len,  
L., and  M. H66k ,  unpub l i shed  observat ions) .  When ~25I-PMs 
and  125I-HSPGs (const i tu t ing  40% o f  the  total  p rote in  or 10% 
of  the  total  t25I-radioactivity) were mixed,  the  prec ip i tat ion of  
~25I-HSPGs was as eff ic ient as with ~2SI-HSPGs a lone,  indicat-  
ing that  p lasma membrane  prote ins  do not  inh ib i t  ant ibody  
b ind ing.  
D igest ion o f  the ~25I-HSPGs with a pur i f ied platelet hepar -  
i t inase (3) and  the presence o f  un labe led  hepar in  d id  not  affect 
the amount  o f  HSPGs  precip i tated,  suggest ing that  the  ant i -  
body  recognizes determinants  on  the  core pro te in - -not  the  
po lysacchar ide  cha ins - -o f  these  HSPGs .  
By SDS PAGE (Fig. l), immunoprec ip i ta tes  obta ined  f rom 
t25I-HSPGs or  a mix ture  o f  the  latter and  t25I-PMs with 
[-IGURE ] (A) Samples of 12~l-labeled rat liver plasma membrane 
fractions (usI-PMs) (80,000 cpm; lane I) and purified 12SI-HSPGs 
(20,000 cpm; lane 2) were separated by SDS PAGE and exposed 
for autoradiography. ~2sI-PMs contain numerous labeled protein 
bands, and ~2SI-HSPGs appear as a typical broad band concentrated 
at the interface of the stacking and running gels. (B) Autoradiograms 
of immunoprecipitates obtained when anti-HSPG serum (lanes 3- 
5) or normal rabbit serum (lanes 6-8) were incubated with ~2Sl- 
HSPGs alone (lanes 3 and 6), with a mixture of 12SI-HSPGs and ~2sl- 
PMs (lanes 4 and 7), or with ~251-PMs alone (lanes 5 and 8). A 
smeared band at the top of the gel corresponding to HSPGs was 
precipitated by the anti-HSPG serum from ~2SI-HSPGs (lane 3) and 
from the mixture of ~2SI-HSPGs and 12SI-PMs (lane 4), but not from 
12sI-PMs alone (lane 5). No such bands were precipitated with 
normal rabbit serum (lanes 6 8). The narrow band at the top of the 
stacking gel (lanes 5, 7, and 8) is considered to be nonspecific since 
it is present with both normal and immune sera. 
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immune serum were identical to that of purified 125I-HSPGs-- 
i.e., the labeled material accumulated atthe interface between 
the stacking and running gel, and no other protein bands were 
precipitated. (Compare lanes 2, 3, and 4). No labeled material 
was precipitated from 125I-HSPGs with normal rabbit serum 
(lanes 6-8) or from '25I-PMs with immune serum (lane 5). 
Enzyme-linked immunosorbent assays analyses showed no 
reactivity of the antiserum with laminin, fibronectin, or Type 
IV collagen (data not shown). 
Collectively, these data indicate that the antiserum gener- 
ated against liver membrane HSPGs recognizes the core pro- 
tein of membrane HSPGs but does not react with plasma 
membrane proteins or with common extracellular matrix 
constituents. 
Immunoprecipitation f 35S-HSPGs 
To establish which forms of cell-associated HSPGs are 
recognized by the antibody, we carried out immunoprecipi- 
tations with 35S-HSPGs isolated from primary cultures of rat 
hepatocytes. Up to 50% of the membrane-intercalated 35S-
HSPGs but only - 12% of the heparin-releasable 35S-HSPGs 
was precipitated by the antibody (Fig. 2). There was no 
reactivity with the 355-HS oligosaccharide (Fig. 2) as antigen 
or when the antiserum was substituted with normal rabbit 
serum (not shown). 
Localization of HSPGs in Rat Liver 
When 0.5-#m ultracryomicrotome sections were incubated 
with anti-HSPG serum or IgG for immunofluorescence, stain- 
ing was een around the hepatic sinsuoids (Fig. 3 A). A similar 
distribution of reaction product was seen in 0.5-um sections 
of plastic-embedded immunoperoxidase preparations (Fig. 
3B). Some foci ofintracellular staining were also seen in the 
hepatocyte cytoplasm in the latter. No staining was detected 
in sections imilarly reacted with normal rabbit serum. 
When immunoperoxidase preparations were examined by 
electron microscopy (Figs. 4-6 and 8-9), it was evident hat 
the staining seen around the hepatic sinusoids by light mi- 
croscopy was due to its presence on the hepatocyte c ll surface 
facing the space of Disse (Figs. 4 and 8), and that there was 
little staining of the endothelial and Kupffer cell surfaces. In 
50 
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FIGURE 2 Different forms of 35S-HSPGs or HS oligosaccharides 
(5,000 cpm) were incubated with indicated amounts of anti-HSPG 
IgG. After incubation with protein A-Sepharose, the percentage of 
3SS-radioactivity bound to the gel was determined. Precipitation of 
intercalated membrane 35S-HSPGs (O) is more efficient han that of 
peripheral (heparin-released) 35S-HSPGs (A). The HS-oligosaccha- 
ride (&) is not recognized. 
FIGURE 3 Localization of HSPGs in rat liver by immunofluores- 
cence (A) (0.5-#m ultracryomicrotome s ction) and by immuno- 
peroxidase (B) (0.5-~,m plastic-embedded section). Staining is con- 
centrated around the hepatic sinusoids (S) in both preparations. 
Staining is also seen intracellularly (arrows) in sites corresponding 
to the location of Golgi complexes (see Figs. 4 and 5). (A) x 150; 
(B) x 98. 
hepatocytes, a continuous layer of reaction product was pres- 
ent all along the microvilli and coated pits at the sinusoidal 
domain, but there was little or no staining of the lateral or 
bile canalicular plasmalemmal domains (Figs. 4 and 5). The 
same concentration of HSPGs on the sinusoidal surface of 
hepatocytes was seen in sections reacted by the immunogold 
procedure,--i.e, gold particles were pr sent in large numbers 
on the sinusoidal cell surface of hepatocytes (Fig. 7), but few 
were seen on endothelial or Kupffer cells or on the lateral or 
bile canalicular surfaces of hepatocytes. 
Within the hepatocyte, staining was present in Golgi and 
endoplasmic reticulum (ER) cisternae (Figs. 4-6) as well as 
in some cytoplasmic vesicles (Fig. 5) and in some endosomes 
and lysosomes (Figs. 8-9). The most regular and prominent 
site of intracellular staining was the Golgi complex where 
reaction product was consistently found in the stacked cister- 
nae (Figs. 5-6). In the majority of cases all the cisternae in a 
given stack were stained, but there was no staining of GERL- 
like structures. Staining of the rough ER was less frequent 
and more patchy; when present, reaction product was typi- 
cally concentrated at the tips of the reactive cisternae (Fig. 5). 
The number of stained endosomes and lysosomes was quite 
variable from one cell to another. 
In controls incubated with normal rabbit serum, no reac- 
tion product was detected in any location. 
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FIGURES 4-6 Electron micrographs demonstrating the localization of HSPGs in rat liver by immunoperoxidase. Fig. 4 is a low 
magnification view of a hepatocyte showing staining of the sinusoidal domain of the hepatocyte cell membrane (cm) facing the 
sinusoid (Sin). The lateral (cm') domain (between the sinusoid and the bile canaliculus [BC]) and the bile canalicular domain 
(facing the bile canaliculus) of the hepatocyte show little or no staining. Staining is also present intracellularly in several Golgi 
complexes (G). Figs. 5 and 6 illustrate the localization of HSPGs in the stacked Golgi cisternae (Gc). Reaction product is seen 
distributed across all of the cisternae in each stack. It is not present in a GERL- or lysosome-like structure (Fig. 6, arrow). Also 
illustrated (Fig. 5) is the presence of reaction product at the tip of an ER cisternae (er) and in several cytoplasmic vesicles (ve), 
and the absence of reaction product from the bile canalicular (BC) and lateral (cm') domains of the plasmalemma. (Fig. 4) 
x 13,500; (Fig. 5) x 39,000; (Fig. 6) x 50,000. 
DISCUSSION 
In this study, we produced a specific antibody to rat liver 
membrane HSPGs and used it to determine the localization 
of HSPGs in the rat liver. Immunoprecipitation a alyses 
established that the antibody generated specifically recognizes 
HSPGs purified from rat liver plasma membrane fractions, 
and it preferentially recognizes the membrane-intercalated 
form of HSPGs. It was concluded that the antibody recognizes 
determinants on the core protein but not on the polysaccha- 
ride chains of these HSPGs because it does not react with HS 
oligosaccharide and because release of the polysaccharide 
chains (by heparitinase digestion) did not affect immunopre- 
cipitation. 
By immunocytoehemistry, we found that the HSPGs ree- 
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FIGURE 7 Portion of a hepatocyte from a section incubated with anti-HSPG IgG and labeled by an indirect immunogold 
procedure. Clumps of gold particles are concentrated on the microvilli (my) at the sinusoidal domain of the hepatocyte and few 
are bound to the endothelial (en) plasmalemma, x 40,000. 
ognized by this antibody are restricted in their distribution to 
hepatocytes where they are concentrated along the sinusoidal 
domain of the plasmalemma. In addition, they are regularly 
found intraceUularly associated with Golgi cisternae and some 
rough ER cisternae, as well as with some of the cytoplasmic 
vesicles, endosomes, and lysosomes. 
Previous biochemical results established that HSPGs are 
present in rat liver plasma membrane fractions (3) prepared 
by the method of Ray (19). Such fractions are assumed to be 
derived primarily from the bile canalicular and lateral do- 
mains of the hepatocyte plasmalemma, but they also contain 
variable amounts of sinusoidal plasma membrane and other 
(e.g., Golgi) membranes as well (24). The present immuno- 
cytochemical results confirm that HSPGs are associated with 
the hepatocyte plasmalemma, nd demonstrate further that 
(a) they are largely restricted to the sinusoidal plasmalemmal 
domain of this cell, (b) they are missing or present in very 
low concentrations on the lateral and bile canalicular do- 
mains, and (c) they are not restricted to the plasma membrane 
but are found in intracellular compartments of hepatocytes 
as well. 
At present here are a number of examples of membrane 
constituents which are highly concentrated or l cated exclu- 
sively on a particular domain of the hepatocyte plasmalemma. 
Some membrane constituents, such as receptors for insulin 
(25), asialoglycoproteins (26), and mannose-6-phosphate (21) 
are found mainly if not exclusively on the sinusoidal domain, 
whereas others, such as (Na÷K+)-ATPase (27) and adenylate 
cyclase (24) are found on both the sinusoidal and lateral 
domains. Still other components, uch as phosphatases and 
leucine aminopeptidase (24), and three membrane glycopro- 
teins (105, 110, and 160 kD) of unknown function (28), are 
restricted to the bile canalicular domain. 
The function of the HSPGs concentrated at the vascular 
surface of the hepatocyte is not known. Previous tudies have 
demonstrated that HSPGs on the surfaces of endothelial cells, 
which, like the sinusoidal surface of the hepatocyte are ex- 
posed to the blood plasma, are able to bind molecules from 
the circulation such as lipoprotein lipase (29) and antithrom- 
bin (30). A role for heparin in modulating binding of low 
density lipoproteins to their receptors has also been postulated 
(31). 
The HSPGs present within the ER and Golgi cisternae of 
hepatocytes most likely represent a biosynthetic pool of 
HSPGs destined for the cell surface since it is known that 
newly synthesized proteoglycans, like glycoproteins, are seg- 
regated in the rough ER and transported to the Golgi complex 
where they undergo extensive posttranslational modification 
(e.g., glycosylation and sulfation) (32). The HSPGs detected 
in endosomes and lysosomes could be destined for degrada- 
tion or could be in transit during recycling (33). The vesicles 
located near the cell surface in which we detected HSPGs are 
probably involved in the transport of HSPGs either from the 
Golgi to the cell surface or from the latter to endosomes and 
lysosomes. However, the possibility that the HSPGs are inte- 
gral components of the membranes of these compartments 
cannot be ruled out at present. Kinetic and cell fractionation 
studies are required to determine the relationship (biosyn- 
thetic, degradative, recycling?) between the HSPGs detected 
in these different organelles. 
The antibody raised against liver HSPGs appears to recog- 
nize plasma membrane-associated HSPGs from tissues other 
than liver because it stains plasma membranes of kidney 
epithelia nd endothelia (34) and of cultured fibroblasts (35). 
However, it does not recognize HSPGs associated with base- 
ment membranes because it does not stain basement mem- 
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FIGURES 8 and 9 Localization of HSPG in endosomes and lyso- 
somes by immunoperoxidase. In Fig. 8, reaction product is seen in 
an endosome (en)--with a tubular connection (arrow)--Iocated 
near the sinusoidal cell surface. The sinusoidal domain of the 
plasmalemma (cm) is also stained. In Fig. 9, reaction produ~:t is 
seen in a presumptive endosome (en) and in a lysosome (/y). (Fig. 
8) x 46,500; (Fig. 9) x 22,000. 
branes in kidney and other tissues (34). Recently an antibody 
was raised against HSPGs purified from rat kidney glomeruli 
that stains basement membranes but does not stain epithelial 
or endothelial plasma membranes in the kidney (36) and in 
other tissues surveyed, including rat liver. These findings 
suggest hat the plasma membrane HSPGs are antigenically 
distinct from the basement membrane-associated HSPGs. 
Further work in progress using anti-HSPG antibodies is aimed 
at determining the relationship between these two populations 
of HSPG. 
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